Related Experiment Video

Updated: Jul 18, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Is the anti-sarcoma and anti-viral cytokine "plasma factor" a novel chicken Y-box protein?

Manohar V N Shirodkar1, Pravin B Sehgal

  • 1Shirodkar Memorial Research Foundation, Mumbai, Pune, India.

Indian Journal of Experimental Biology
|November 30, 2006
PubMed

Insights

Researchers discovered a novel 14-kDa plasma factor (PF) that blocks sarcoma growth and inhibits RNA virus replication, potentially representing a new antiviral cytokine with a unique mechanism. This finding offers new avenues for antiviral therapies.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Early research in the 1960s observed that certain viruses could inhibit tumor development in chickens.
  • This led to the identification of a "sarcoma-blockade" phenomenon.
  • Further investigation focused on characterizing the underlying mechanism and factors involved.

Purpose of the Study:

  • To characterize a circulating factor responsible for anti-sarcoma and anti-viral activity.
  • To determine the nature and potential function of this factor.
  • To explore its relationship with known antiviral mechanisms and cellular proteins.

Main Methods:

  • Observation of viral inhibition of tumor development.
  • Biochemical characterization of the active "plasma factor" (PF).
  • Partial amino acid sequencing and comparison with known protein databases.
  • Analysis of the biological functions of related Y-box family proteins.

Main Results:

  • A 14-kDa circulating factor, termed "plasma factor" (PF), was identified.
  • PF inhibits RNA virus replication but not DNA virus replication, distinguishing it from interferons.
  • Amino acid sequencing suggests PF may be a chicken YB2-like protein.
  • Y-box proteins are known to bind DNA and RNA, regulate transcription, and inhibit viral transformation.

Conclusions:

  • The 14-kDa plasma factor (PF) represents a novel antiviral cytokine.
  • PF likely possesses a unique mechanism of action, distinct from interferons.
  • Its potential role in regulating viral replication and cellular processes warrants further investigation.

More Related Videos

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins10:05

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...